Toxoplasma gondii secreted effectors co-opt host repressor complexes to inhibit necroptosis

Alex Rosenberg1, L David Sibley1

  • 1Department of Molecular Microbiology, Washington University School of Medicine in St. Louis, St. Louis, MO 63130, USA.

Cell Host & Microbe
|May 27, 2021
PubMed

Insights

Toxoplasma gondii uses effector TgNSM to block host cell death pathways, preventing immune responses. This mechanism, involving the NCoR/SMRT complex, ensures parasite survival during chronic infections.

Area of Science:

  • Parasitology
  • Immunology
  • Cell Biology

Background:

  • Toxoplasma gondii manipulates host cells using effector proteins.
  • Interferons activate host defenses, including necroptosis, a form of programmed cell death.
  • The role of T. gondii effectors in targeting interferon-induced cell death pathways was unclear.

Purpose of the Study:

  • To investigate secreted T. gondii effectors that target host cell nucleus.
  • To determine if T. gondii inhibits interferon-driven necroptosis.
  • To elucidate the mechanism by which T. gondii ensures survival in host cells.

Main Methods:

  • Analysis of secreted effector proteins localizing to the host cell nucleus.
  • Investigating the interaction of T. gondii effectors with host transcription factors and complexes.
  • Assessing the impact of effectors on interferon-stimulated gene expression and host cell death.

Main Results:

  • The bradyzoite effector TgNSM targets the NCoR/SMRT complex, inhibiting interferon-regulated genes.
  • TgNSM collaborates with TgIST to suppress the expression of protein kinase R (PKR) and MLKL.
  • This inhibition prevents host cell necroptosis, protecting the parasite's niche.

Conclusions:

  • T. gondii effector TgNSM inhibits host necroptosis by targeting the NCoR/SMRT complex.
  • TgNSM and TgIST cooperate to block interferon-mediated cell death, ensuring parasite survival.
  • This study reveals a novel role for NCoR/SMRT in necroptosis and T. gondii chronic infection.

Related Concept Videos

Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
5.2K
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
13.0K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
7.0K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.2K
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
8.2K